LONG-TERM ASSESSMENT OF SAFETY AND THERAPEUTIC BENEFIT OF VIASKIN® PEANUT EPICUTANEOUS TREATMENT IN PEANUT-ALLERGIC CHILDREN: A 6-MONTH RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY.....

Project: Research project

Project Details

StatusActive
Effective start/end date1/3/17 → 8/31/50

Funding

  • DBV Technologies